-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation